Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Investigative and Clinical Urology|January 4, 2022
Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancerNancy Y Greenland, Matthew R Cooperberg, Anthony C Wong, et al.Journal of Oncology Practice|July 3, 2014
Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancerAnthony C Wong, Shannon Stock, Deborah Schrag, et al.Advances in Radiation Oncology|July 18, 2022
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 TrialKevin Shee, Claire M de la Calle, Albert J Chang, et al.Journal of Virology|July 3, 2020
A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its InhibitionRobert H Bortz, Anthony C Wong, Michael G Grodus, et al.Practical Radiation Oncology|January 17, 2017
A feasibility study of 2-mm bolus for postmastectomy radiation therapyLauren C Das, Daniel W Golden, Eugenia Perevalova, et al.Viruses|May 17, 2012
Structural basis for differential neutralization of ebolavirusesShridhar Bale, Joao M Dias, Marnie L Fusco, et al.Oncotarget|April 2, 2016
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAsDiana Rose E Ranoa, Akash D Parekh, Sean P Pitroda, et al.Cancer|May 21, 2016
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)Anthony C Wong, Sydeaka P Watson, Sean P Pitroda, et al.Nature Structural & Molecular Biology|November 22, 2011
A shared structural solution for neutralizing ebolavirusesJoão M Dias, Ana I Kuehne, Dafna M Abelson, et al.Nature|August 26, 2011
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1Jan E Carette, Matthijs Raaben, Anthony C Wong, et al.Pageof 3